SS Innovations International (NASDAQ:SSII) Stock Price Up 12.5% - Still a Buy?

Key Points

• SS Innovations International shares jumped 12.5% to about $2.53, although trading volume was 83% below the stock’s average daily volume.
• Analyst sentiment remains negative: the consensus rating is “Sell” from one analyst, despite Wall Street Zen upgrading the stock to “Hold.” The consensus price target is $7.00.
• The company reported a quarterly loss of $0.01 per share on $13.94 million in revenue, alongside a negative net margin of 23.73% and negative return on equity of 26.77%.

Shares of SS Innovations International, Inc. (NASDAQ:SSII - Get Free Report) shot up 12.5% during trading on Monday. The company traded as high as $2.50 and last traded at $2.5310. 11,636 shares traded hands during trading, a decline of 83% from the average daily volume of 69,203 shares. The stock had previously closed at $2.25.

Analyst Ratings Changes

A number of equities analysts recently commented on SSII shares. Wall Street Zen raised shares of SS Innovations International from a "sell" rating to a "hold" rating in a research note on Sunday, June 28th. Weiss Ratings reiterated a "sell (e+)" rating on shares of SS Innovations International in a research note on Thursday, October 15th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock currently has a consensus rating of "Sell" and a consensus price target of $7.00.

SS Innovations International Stock Up 8.3%

The firm has a market cap of $488.33 million, a P/E ratio of -40.83 and a beta of -1.79. The firm's 50-day moving average price is $3.08 and its 200 day moving average price is $3.62.

SS Innovations International (NASDAQ:SSII - Get Free Report) last announced its earnings results on Thursday, August 13th. The company reported ($0.01) EPS for the quarter. SS Innovations International had a negative net margin of 23.73% and a negative return on equity of 26.77%. The company had revenue of $13.94 million for the quarter.

Insider Buying and Selling at SS Innovations International

In other SS Innovations International news, CEO Srivastava Sudhir sold 33,333 shares of the stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $3.00, for a total value of $99,999.00. Following the transaction, the chief executive officer owned 108,520,928 shares of the company's stock, valued at approximately $325,562,784. This represents a 0.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Hedge Funds Weigh In On SS Innovations International

A hedge fund recently raised its position in SS Innovations International stock. Inspire Investing LLC boosted its position in SS Innovations International, Inc. (NASDAQ:SSII - Free Report) by 19.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 223,053 shares of the company's stock after acquiring an additional 36,756 shares during the quarter. Inspire Investing LLC owned 0.11% of SS Innovations International worth $665,000 at the end of the most recent reporting period.

SS Innovations International Company Profile

SS Innovations International, Inc is a medical technology company focused on developing and commercializing robotic-assisted surgical systems. Its principal product is the SSi Mantra surgical robotic system, which is designed to support surgeons in performing minimally invasive procedures across a range of specialties.

The company also develops related surgical instruments, accessories, and technology intended to complement the SSi Mantra platform. Its products are designed to help hospitals expand access to robotic-assisted surgery while supporting precision, visualization, and surgeon control during procedures.

SS Innovations was founded by Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.